Overview

Cisplatin and Nab-paclitaxel for (N2) Defined NSCLC

Status:
Terminated
Trial end date:
2016-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this research study is to determine whether giving cisplatin and nab-paclitaxel before surgery will reduce the presence of disease in certain areas of the lung at the time of surgery.
Phase:
Phase 2
Details
Lead Sponsor:
UNC Lineberger Comprehensive Cancer Center
Treatments:
Albumin-Bound Paclitaxel
Cisplatin
Gemcitabine
Paclitaxel
Pemetrexed